APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psychobiotic Supplements

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Psychobiotic Supplements Market Outlook and Growth Opportunities 2026

31 December 2025197 pages

Choose your research edition.

Industry ResearchPsychobiotic Supplements Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Psychobiotic Supplements Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Psychobiotic Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psychobiotic Supplements Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Psychobiotic Supplements Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Psychobiotic Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Psychobiotic Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Psychobiotic Supplements market include Life Extension, Lifted Naturals, NEURAXPHARM, Uplift Food Pty Ltd., Nutrimmun GmbH, InnovixLabs, Optibac Probiotics, Seraphina Therapeutics and SFI Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Psychobiotic Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Psychobiotic Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Psychobiotic Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Psychobiotic Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Psychobiotic Supplements Segment by Company

Life Extension

Lifted Naturals

NEURAXPHARM

Uplift Food Pty Ltd.

Nutrimmun GmbH

InnovixLabs

Optibac Probiotics

Seraphina Therapeutics

SFI Health

Microbiome Labs

G1 NUTRITION

Psychobiotic Supplements Segment by Type

Capsules

Tablets

Other

Psychobiotic Supplements Segment by Application

Offline Sales

Online Sales

Psychobiotic Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Psychobiotic Supplements status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Psychobiotic Supplements market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Psychobiotic Supplements significant trends, drivers, influence factors in global and regions.

6. To analyze Psychobiotic Supplements competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psychobiotic Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psychobiotic Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psychobiotic Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Psychobiotic Supplements market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Psychobiotic Supplements industry.

Chapter 3: Detailed analysis of Psychobiotic Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Psychobiotic Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Psychobiotic Supplements in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Psychobiotic Supplements Industry Trends Table 2. Psychobiotic Supplements Industry Drivers Table 3. Psychobiotic Supplements Industry Opportunities and Challenges Table 4. Psychobiotic Supplements Industry Restraints Table 5. Global Psychobiotic Supplements Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Psychobiotic Supplements Revenue Share by Company (2021-2026) Table 7. Global Psychobiotic Supplements Sales Volume by Company (k units) & (2021-2026) Table 8. Global Psychobiotic Supplements Sales Volume Share by Company (2021-2026) Table 9. Global Psychobiotic Supplements Average Price (USD/unit) of Company (2021-2026) Table 10. Global Psychobiotic Supplements Company Ranking, (2024-2026) & (USD Million) Table 11. Global Psychobiotic Supplements Key Company Manufacturing Base & Headquarters Table 12. Global Psychobiotic Supplements Company, Product Type & Application Table 13. Global Psychobiotic Supplements Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Psychobiotic Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsules Table 18. Significant Companies of Tablets Table 19. Significant Companies of Other Table 20. Global Psychobiotic Supplements Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Psychobiotic Supplements Sales Volume by Type (2021-2026) & (k units) Table 22. Global Psychobiotic Supplements Sales Volume by Type (2027-2032) & (k units) Table 23. Global Psychobiotic Supplements Sales Volume Share by Type (2021-2026) Table 24. Global Psychobiotic Supplements Sales Volume Share by Type (2027-2032) Table 25. Global Psychobiotic Supplements Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Psychobiotic Supplements Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Psychobiotic Supplements Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Psychobiotic Supplements Sales Value Share by Type (2021-2026) Table 29. Global Psychobiotic Supplements Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Offline Sales Table 31. Significant Companies of Online Sales Table 32. Global Psychobiotic Supplements Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Psychobiotic Supplements Sales Volume by Application (2021-2026) & (k units) Table 34. Global Psychobiotic Supplements Sales Volume by Application (2027-2032) & (k units) Table 35. Global Psychobiotic Supplements Sales Volume Share by Application (2021-2026) Table 36. Global Psychobiotic Supplements Sales Volume Share by Application (2027-2032) Table 37. Global Psychobiotic Supplements Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Psychobiotic Supplements Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Psychobiotic Supplements Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Psychobiotic Supplements Sales Value Share by Application (2021-2026) Table 41. Global Psychobiotic Supplements Sales Value Share by Application (2027-2032) Table 42. Global Psychobiotic Supplements Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Psychobiotic Supplements Sales by Region (2021-2026) & (k units) Table 44. Global Psychobiotic Supplements Sales Market Share by Region (2021-2026) Table 45. Global Psychobiotic Supplements Sales by Region (2027-2032) & (k units) Table 46. Global Psychobiotic Supplements Sales Market Share by Region (2027-2032) Table 47. Global Psychobiotic Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Psychobiotic Supplements Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Psychobiotic Supplements Sales Value Share by Region (2021-2026) Table 50. Global Psychobiotic Supplements Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Psychobiotic Supplements Sales Value Share by Region (2027-2032) Table 52. Global Psychobiotic Supplements Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Psychobiotic Supplements Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Psychobiotic Supplements Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Psychobiotic Supplements Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 57. Global Psychobiotic Supplements Sales Market Share by Country (2021-2026) Table 58. Global Psychobiotic Supplements Sales by Country (2027-2032) & (k units) Table 59. Global Psychobiotic Supplements Sales Market Share by Country (2027-2032) Table 60. Global Psychobiotic Supplements Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Psychobiotic Supplements Sales Value Market Share by Country (2021-2026) Table 62. Global Psychobiotic Supplements Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Psychobiotic Supplements Sales Value Market Share by Country (2027-2032) Table 64. Life Extension Company Information Table 65. Life Extension Business Overview Table 66. Life Extension Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Life Extension Psychobiotic Supplements Product Portfolio Table 68. Life Extension Recent Development Table 69. Lifted Naturals Company Information Table 70. Lifted Naturals Business Overview Table 71. Lifted Naturals Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Lifted Naturals Psychobiotic Supplements Product Portfolio Table 73. Lifted Naturals Recent Development Table 74. NEURAXPHARM Company Information Table 75. NEURAXPHARM Business Overview Table 76. NEURAXPHARM Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. NEURAXPHARM Psychobiotic Supplements Product Portfolio Table 78. NEURAXPHARM Recent Development Table 79. Uplift Food Pty Ltd. Company Information Table 80. Uplift Food Pty Ltd. Business Overview Table 81. Uplift Food Pty Ltd. Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio Table 83. Uplift Food Pty Ltd. Recent Development Table 84. Nutrimmun GmbH Company Information Table 85. Nutrimmun GmbH Business Overview Table 86. Nutrimmun GmbH Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Nutrimmun GmbH Psychobiotic Supplements Product Portfolio Table 88. Nutrimmun GmbH Recent Development Table 89. InnovixLabs Company Information Table 90. InnovixLabs Business Overview Table 91. InnovixLabs Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. InnovixLabs Psychobiotic Supplements Product Portfolio Table 93. InnovixLabs Recent Development Table 94. Optibac Probiotics Company Information Table 95. Optibac Probiotics Business Overview Table 96. Optibac Probiotics Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Optibac Probiotics Psychobiotic Supplements Product Portfolio Table 98. Optibac Probiotics Recent Development Table 99. Seraphina Therapeutics Company Information Table 100. Seraphina Therapeutics Business Overview Table 101. Seraphina Therapeutics Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Seraphina Therapeutics Psychobiotic Supplements Product Portfolio Table 103. Seraphina Therapeutics Recent Development Table 104. SFI Health Company Information Table 105. SFI Health Business Overview Table 106. SFI Health Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. SFI Health Psychobiotic Supplements Product Portfolio Table 108. SFI Health Recent Development Table 109. Microbiome Labs Company Information Table 110. Microbiome Labs Business Overview Table 111. Microbiome Labs Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Microbiome Labs Psychobiotic Supplements Product Portfolio Table 113. Microbiome Labs Recent Development Table 114. G1 NUTRITION Company Information Table 115. G1 NUTRITION Business Overview Table 116. G1 NUTRITION Psychobiotic Supplements Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. G1 NUTRITION Psychobiotic Supplements Product Portfolio Table 118. G1 NUTRITION Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Psychobiotic Supplements Distributors List Table 122. Psychobiotic Supplements Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Psychobiotic Supplements Product Image Figure 2. Global Psychobiotic Supplements Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psychobiotic Supplements Sales Value (2021-2032) & (US$ Million) Figure 4. Global Psychobiotic Supplements Sales (2021-2032) & (k units) Figure 5. Global Psychobiotic Supplements Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Psychobiotic Supplements Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsules Image Figure 10. Tablets Image Figure 11. Other Image Figure 12. Global Psychobiotic Supplements Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Psychobiotic Supplements Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Psychobiotic Supplements Sales Volume Share by Type (2021-2032) Figure 15. Global Psychobiotic Supplements Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Psychobiotic Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Psychobiotic Supplements Sales Value Share by Type (2021-2032) Figure 18. Offline Sales Image Figure 19. Online Sales Image Figure 20. Global Psychobiotic Supplements Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Psychobiotic Supplements Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Psychobiotic Supplements Sales Volume Share by Application (2021-2032) Figure 23. Global Psychobiotic Supplements Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Psychobiotic Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Psychobiotic Supplements Sales Value Share by Application (2021-2032) Figure 26. Global Psychobiotic Supplements Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Psychobiotic Supplements Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Psychobiotic Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Psychobiotic Supplements Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Psychobiotic Supplements Sales Value (2021-2032) & (US$ Million) Figure 31. North America Psychobiotic Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Psychobiotic Supplements Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Psychobiotic Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Psychobiotic Supplements Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Psychobiotic Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Psychobiotic Supplements Sales Value (2021-2032) & (US$ Million) Figure 37. South America Psychobiotic Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Psychobiotic Supplements Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Psychobiotic Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Psychobiotic Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Psychobiotic Supplements Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Psychobiotic Supplements Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
  • Other
Applications
  • Offline Sales
  • Online Sales
Companies covered
  • Life Extension
  • Lifted Naturals
  • NEURAXPHARM
  • Uplift Food Pty Ltd.
  • Nutrimmun GmbH
  • InnovixLabs
  • Optibac Probiotics
  • Seraphina Therapeutics
  • SFI Health
  • Microbiome Labs
  • G1 NUTRITION

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Psychobiotic Supplements Sales Value (2021-2032)
  4. 1.2.2 Global Psychobiotic Supplements Sales Volume (2021-2032)
  5. 1.2.3 Global Psychobiotic Supplements Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Psychobiotic Supplements Market Dynamics
  1. 2.1 Psychobiotic Supplements Industry Trends
  2. 2.2 Psychobiotic Supplements Industry Drivers
  3. 2.3 Psychobiotic Supplements Industry Opportunities and Challenges
  4. 2.4 Psychobiotic Supplements Industry Restraints
3 Psychobiotic Supplements Market by Company
  1. 3.1 Global Psychobiotic Supplements Company Revenue Ranking in 2025
  2. 3.2 Global Psychobiotic Supplements Revenue by Company (2021-2026)
  3. 3.3 Global Psychobiotic Supplements Sales Volume by Company (2021-2026)
  4. 3.4 Global Psychobiotic Supplements Average Price by Company (2021-2026)
  5. 3.5 Global Psychobiotic Supplements Company Ranking (2024-2026)
  6. 3.6 Global Psychobiotic Supplements Company Manufacturing Base and Headquarters
  7. 3.7 Global Psychobiotic Supplements Company Product Type and Application
  8. 3.8 Global Psychobiotic Supplements Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Psychobiotic Supplements Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Psychobiotic Supplements Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Psychobiotic Supplements Market by Type
  1. 4.1 Psychobiotic Supplements Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Tablets
  4. 4.1.3 Other
  5. 4.2 Global Psychobiotic Supplements Sales Volume by Type
  6. 4.2.1 Global Psychobiotic Supplements Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Psychobiotic Supplements Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Psychobiotic Supplements Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Psychobiotic Supplements Sales Value by Type
  10. 4.3.1 Global Psychobiotic Supplements Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Psychobiotic Supplements Sales Value by Type (2021-2032)
  12. 4.3.3 Global Psychobiotic Supplements Sales Value Share by Type (2021-2032)
5 Psychobiotic Supplements Market by Application
  1. 5.1 Psychobiotic Supplements Application Introduction
  2. 5.1.1 Offline Sales
  3. 5.1.2 Online Sales
  4. 5.2 Global Psychobiotic Supplements Sales Volume by Application
  5. 5.2.1 Global Psychobiotic Supplements Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Psychobiotic Supplements Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Psychobiotic Supplements Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Psychobiotic Supplements Sales Value by Application
  9. 5.3.1 Global Psychobiotic Supplements Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Psychobiotic Supplements Sales Value by Application (2021-2032)
  11. 5.3.3 Global Psychobiotic Supplements Sales Value Share by Application (2021-2032)
6 Psychobiotic Supplements Regional Sales and Value Analysis
  1. 6.1 Global Psychobiotic Supplements Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Psychobiotic Supplements Sales by Region (2021-2032)
  3. 6.2.1 Global Psychobiotic Supplements Sales by Region: 2021-2026
  4. 6.2.2 Global Psychobiotic Supplements Sales by Region (2027-2032)
  5. 6.3 Global Psychobiotic Supplements Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Psychobiotic Supplements Sales Value by Region (2021-2032)
  7. 6.4.1 Global Psychobiotic Supplements Sales Value by Region: 2021-2026
  8. 6.4.2 Global Psychobiotic Supplements Sales Value by Region (2027-2032)
  9. 6.5 Global Psychobiotic Supplements Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Psychobiotic Supplements Sales Value (2021-2032)
  12. 6.6.2 North America Psychobiotic Supplements Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Psychobiotic Supplements Sales Value (2021-2032)
  15. 6.7.2 Europe Psychobiotic Supplements Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Psychobiotic Supplements Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Psychobiotic Supplements Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Psychobiotic Supplements Sales Value (2021-2032)
  21. 6.9.2 South America Psychobiotic Supplements Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Psychobiotic Supplements Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Psychobiotic Supplements Sales Value Share by Country, 2025 VS 2032
7 Psychobiotic Supplements Country-level Sales and Value Analysis
  1. 7.1 Global Psychobiotic Supplements Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Psychobiotic Supplements Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Psychobiotic Supplements Sales by Country (2021-2032)
  4. 7.3.1 Global Psychobiotic Supplements Sales by Country (2021-2026)
  5. 7.3.2 Global Psychobiotic Supplements Sales by Country (2027-2032)
  6. 7.4 Global Psychobiotic Supplements Sales Value by Country (2021-2032)
  7. 7.4.1 Global Psychobiotic Supplements Sales Value by Country (2021-2026)
  8. 7.4.2 Global Psychobiotic Supplements Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Psychobiotic Supplements Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Psychobiotic Supplements Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Psychobiotic Supplements Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Life Extension
  2. 8.1.1 Life Extension Company Information
  3. 8.1.2 Life Extension Business Overview
  4. 8.1.3 Life Extension Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Life Extension Psychobiotic Supplements Product Portfolio
  6. 8.1.5 Life Extension Recent Developments
  7. 8.2 Lifted Naturals
  8. 8.2.1 Lifted Naturals Company Information
  9. 8.2.2 Lifted Naturals Business Overview
  10. 8.2.3 Lifted Naturals Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lifted Naturals Psychobiotic Supplements Product Portfolio
  12. 8.2.5 Lifted Naturals Recent Developments
  13. 8.3 NEURAXPHARM
  14. 8.3.1 NEURAXPHARM Company Information
  15. 8.3.2 NEURAXPHARM Business Overview
  16. 8.3.3 NEURAXPHARM Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 NEURAXPHARM Psychobiotic Supplements Product Portfolio
  18. 8.3.5 NEURAXPHARM Recent Developments
  19. 8.4 Uplift Food Pty Ltd.
  20. 8.4.1 Uplift Food Pty Ltd. Company Information
  21. 8.4.2 Uplift Food Pty Ltd. Business Overview
  22. 8.4.3 Uplift Food Pty Ltd. Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio
  24. 8.4.5 Uplift Food Pty Ltd. Recent Developments
  25. 8.5 Nutrimmun GmbH
  26. 8.5.1 Nutrimmun GmbH Company Information
  27. 8.5.2 Nutrimmun GmbH Business Overview
  28. 8.5.3 Nutrimmun GmbH Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nutrimmun GmbH Psychobiotic Supplements Product Portfolio
  30. 8.5.5 Nutrimmun GmbH Recent Developments
  31. 8.6 InnovixLabs
  32. 8.6.1 InnovixLabs Company Information
  33. 8.6.2 InnovixLabs Business Overview
  34. 8.6.3 InnovixLabs Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 InnovixLabs Psychobiotic Supplements Product Portfolio
  36. 8.6.5 InnovixLabs Recent Developments
  37. 8.7 Optibac Probiotics
  38. 8.7.1 Optibac Probiotics Company Information
  39. 8.7.2 Optibac Probiotics Business Overview
  40. 8.7.3 Optibac Probiotics Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Optibac Probiotics Psychobiotic Supplements Product Portfolio
  42. 8.7.5 Optibac Probiotics Recent Developments
  43. 8.8 Seraphina Therapeutics
  44. 8.8.1 Seraphina Therapeutics Company Information
  45. 8.8.2 Seraphina Therapeutics Business Overview
  46. 8.8.3 Seraphina Therapeutics Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Seraphina Therapeutics Psychobiotic Supplements Product Portfolio
  48. 8.8.5 Seraphina Therapeutics Recent Developments
  49. 8.9 SFI Health
  50. 8.9.1 SFI Health Company Information
  51. 8.9.2 SFI Health Business Overview
  52. 8.9.3 SFI Health Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 SFI Health Psychobiotic Supplements Product Portfolio
  54. 8.9.5 SFI Health Recent Developments
  55. 8.10 Microbiome Labs
  56. 8.10.1 Microbiome Labs Company Information
  57. 8.10.2 Microbiome Labs Business Overview
  58. 8.10.3 Microbiome Labs Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Microbiome Labs Psychobiotic Supplements Product Portfolio
  60. 8.10.5 Microbiome Labs Recent Developments
  61. 8.11 G1 NUTRITION
  62. 8.11.1 G1 NUTRITION Company Information
  63. 8.11.2 G1 NUTRITION Business Overview
  64. 8.11.3 G1 NUTRITION Psychobiotic Supplements Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 G1 NUTRITION Psychobiotic Supplements Product Portfolio
  66. 8.11.5 G1 NUTRITION Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Psychobiotic Supplements Value Chain Analysis
  2. 9.1.1 Psychobiotic Supplements Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Psychobiotic Supplements Sales Mode & Process
  6. 9.2 Psychobiotic Supplements Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Psychobiotic Supplements Distributors
  9. 9.2.3 Psychobiotic Supplements Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst